Press Release: INVESTOR DEADLINE TOMORROW: Robbins Geller Rudman & Dowd LLP Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - EW
SAN DIEGO, Dec. 12, 2024 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Edwards Lifesciences Corporation (NYSE: EW) securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”), have until this upcoming Friday, December 13, 2024 to seek appointment as lead…
Press Release: INVESTOR DEADLINE TOMORROW: Robbins Geller Rudman & Dowd LLP Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - EW - Newscast
Tue, 22 Apr 2025 14:56:00 GMT Investor Deadline: Investors who purchased or acquired ROCKET LAB securities during the Class Period may, no later than APRIL 28, 2025, seek to be appointed as a lead plaintiff representative of ...
Tue, 22 Apr 2025 07:35:00 GMT and reminds investors of the April 23, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading ...
Sun, 13 Apr 2025 11:38:00 GMT NEW YORK, April 13, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm ... 2025 lead plaintiff deadline. So what: If you purchased Merck securities during the Class Period ...
